Next, using CCLE, we showed that TGFB1 were highly expressed in malignant hematological cell lines from chronic myeloid leukemia (CML), AML, chronic lymphocytic leukemia (CLL), and DLBCL (Fig. 1B). Here, TGFB1 is linked to B-cell chronic lymphocytic leukemia.